Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study
Phase of Trial: Phase IV
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Dolutegravir (Primary) ; Lamivudine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms PADDLE
- 10 Aug 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 21 Aug 2016 Planned End Date changed from 1 Apr 2016 to 1 Feb 2017.